Skystar Bio-Pharmaceutical Co - ESG Rating & Company Profile powered by AI
The Disclosure rating covers seventeen UN SDGs including: 'Good Health & Wellbeing', 'Industry, Innovation & Infrastructure' and 'Life on Land'. Jump to the bottom of this webpage for potential risks for Skystar Bio-Pharmaceutical Co based on industry, location and size. Complete ESG assessment of Skystar Bio-Pharmaceutical Co are accessed by logging in.
Skystar Bio-Pharmaceutical Co in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Analytik Jena AG | 8.0 | High |
1 | Amniotics AB (publ) | 8.0 | High |
... | ... | ... | |
179 | Exagen Inc | 0.7 | Low |
179 | Mertiva AB | 0.7 | Low |
182 | Skystar Bio-Pharmaceutical Co | 0.0 | Low |
182 | Cadus Corp | 0.0 | Low |
182 | Cambridge Chocolate Technologies SA | 0.0 | Low |
182 | Wesana Health Holdings Inc | 0.0 | Low |
182 | rEVO Biologics Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Skystar Bio-Pharmaceutical Co have an accelerator or VC vehicle to help deliver innovation?
Does Skystar Bio-Pharmaceutical Co disclose current and historical energy intensity?
Does Skystar Bio-Pharmaceutical Co report the average age of the workforce?
Does Skystar Bio-Pharmaceutical Co reference operational or capital allocation in relation to climate change?
Does Skystar Bio-Pharmaceutical Co disclose its ethnicity pay gap?
Does Skystar Bio-Pharmaceutical Co disclose cybersecurity risks?
Does Skystar Bio-Pharmaceutical Co use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Skystar Bio-Pharmaceutical Co offer flexible work?
Does Skystar Bio-Pharmaceutical Co have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Skystar Bio-Pharmaceutical Co disclose the number of employees in R&D functions?
Does Skystar Bio-Pharmaceutical Co plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Skystar Bio-Pharmaceutical Co conduct supply chain audits?
Does Skystar Bio-Pharmaceutical Co disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Skystar Bio-Pharmaceutical Co conduct 360 degree staff reviews?
Does Skystar Bio-Pharmaceutical Co disclose the individual responsible for D&I?
Does Skystar Bio-Pharmaceutical Co disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Skystar Bio-Pharmaceutical Co disclose current and / or historical scope 2 emissions?
Does Skystar Bio-Pharmaceutical Co disclose water use targets?
Does Skystar Bio-Pharmaceutical Co have careers partnerships with academic institutions?
Did Skystar Bio-Pharmaceutical Co have a product recall in the last two years?
Does Skystar Bio-Pharmaceutical Co disclose incidents of discrimination?
Does Skystar Bio-Pharmaceutical Co allow for Work Councils/Collective Agreements to be formed?
Has Skystar Bio-Pharmaceutical Co issued a profit warning in the past 24 months?
Does Skystar Bio-Pharmaceutical Co disclose parental leave metrics?
Does Skystar Bio-Pharmaceutical Co disclose climate scenario or pathway analysis?
Does Skystar Bio-Pharmaceutical Co disclose current and / or historical scope 1 emissions?
Does Skystar Bio-Pharmaceutical Co explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Skystar Bio-Pharmaceutical Co disclose the pay ratio of women to men?
Does Skystar Bio-Pharmaceutical Co support suppliers with sustainability related research and development?
Does Skystar Bio-Pharmaceutical Co disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Skystar Bio-Pharmaceutical Co reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Skystar Bio-Pharmaceutical Co involved in embryonic stem cell research?
Does Skystar Bio-Pharmaceutical Co disclose GHG and Air Emissions intensity?
Does Skystar Bio-Pharmaceutical Co disclose its waste policy?
Does Skystar Bio-Pharmaceutical Co report according to TCFD requirements?
Does Skystar Bio-Pharmaceutical Co plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Skystar Bio-Pharmaceutical Co disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Skystar Bio-Pharmaceutical Co disclose energy use targets?
Does Skystar Bio-Pharmaceutical Co disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Skystar Bio-Pharmaceutical Co have a policy relating to cyber security?
Have a different question?
Potential Risks for Skystar Bio-Pharmaceutical Co
These potential risks are based on the size, segment and geographies of the company.